What is the appropriate systemic corticosteroid dose (e.g., oral prednisolone) for a 4‑year‑old child with asthma weighing about 15 kg during an acute exacerbation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Steroid Dosing for 4-Year-Old with Asthma Exacerbation

For a 4-year-old child (~15 kg) with an acute asthma exacerbation, prescribe oral prednisolone 1–2 mg/kg/day (15–30 mg) divided into two doses daily for 3–10 days without tapering, continuing until symptoms resolve and peak expiratory flow reaches ≥70% of predicted or personal best. 1

Weight-Based Dosing Calculation

  • Calculate the dose as 1–2 mg/kg/day for this 15 kg child, yielding 15–30 mg daily, divided into two doses (e.g., 7.5–15 mg twice daily). 1, 2
  • The maximum daily dose is capped at 60 mg regardless of weight; for a 15 kg child, this cap is not reached. 1, 2
  • Start at 1 mg/kg/day (15 mg total) for mild-to-moderate exacerbations where the child can speak in sentences, has SpO₂ >92% on room air, and peak flow >50% predicted. 1
  • Use 2 mg/kg/day (30 mg total) for severe exacerbations characterized by difficulty speaking, SpO₂ <92%, peak flow <50% predicted, or poor response to initial bronchodilators. 1

Route of Administration

  • Oral prednisolone is strongly preferred and equally effective as intravenous therapy when the child can tolerate oral intake and has intact gastrointestinal absorption. 1, 2
  • Reserve intravenous hydrocortisone (4 mg/kg every 8 hours) only for children who are actively vomiting, severely ill, or unable to swallow. 1

Treatment Duration and Tapering

  • Continue oral prednisolone for 3–10 days; a typical outpatient course is 5 days once symptoms resolve and peak flow reaches ≥70% of predicted. 1, 2
  • No tapering is required for courses shorter than 7–10 days, especially when the child is already on inhaled corticosteroids; tapering may lead to under-dosing during the critical recovery period. 1

Timing of Administration

  • Administer systemic corticosteroids immediately upon recognition of a moderate-to-severe exacerbation; anti-inflammatory effects become clinically apparent within 6–12 hours, making early administration essential. 1
  • Consider systemic corticosteroids at the onset of a viral respiratory infection if the patient has a history of severe exacerbations. 3

Concurrent Essential Therapies

  • Deliver nebulized salbutamol 2.5 mg (for children <15 kg) or 5 mg (for children ≥15 kg) every 20 minutes for three doses, then every 1–4 hours as needed. 1
  • For a 15 kg child, use 2.5 mg salbutamol per nebulization initially. 1
  • Add ipratropium bromide 0.25 mg to each salbutamol nebulization for severe exacerbations, repeating every 6 hours until clinical improvement begins. 1
  • Provide supplemental oxygen via face mask to maintain SpO₂ >92%. 1
  • Continue or initiate inhaled corticosteroids at a higher dose than the pre-exacerbation regimen. 1

Monitoring Response

  • Measure peak expiratory flow 15–30 minutes after initial treatment and then every 4 hours to assess response. 1
  • Maintain continuous pulse-oximetry targeting SpO₂ >92%. 1
  • If no improvement is observed within 15–30 minutes of the first bronchodilator and corticosteroid dose, increase nebulized β-agonist frequency to every 30 minutes and consider transfer to a pediatric intensive care unit. 1

Dosing Pitfalls to Avoid

  • Do not use 2 mg/kg/day (30 mg) for mild-to-moderate exacerbations; the higher dose increases behavioral side effects (anxiety, hyperactivity, aggression) without delivering additional clinical benefit. 4
  • Do not delay systemic corticosteroid administration while repeatedly giving bronchodilators alone; under-use of corticosteroids is a documented cause of preventable asthma deaths. 1
  • Do not taper short courses (<7–10 days); tapering is unnecessary and may lead to under-dosing during the critical recovery period. 1
  • Never use sedatives in a child with acute asthma; they are contraindicated and may be fatal. 1

Alternative Corticosteroid Options

  • Oral prednisone can be substituted for prednisolone at the same dose (1–2 mg/kg/day, maximum 60 mg/day). 1, 2
  • A single oral dose of dexamethasone 0.3 mg/kg has been shown to be non-inferior to a 3–5 day course of prednisolone for mild-to-moderate exacerbations, offering easier administration and better compliance; however, dexamethasone-treated children have a higher rate of requiring additional systemic steroids within 14 days (≈13% vs 4%). 1, 5
  • Despite the convenience of dexamethasone, prednisolone/prednisone remains the guideline-recommended standard for pediatric acute asthma exacerbations. 1, 2

Discharge Planning

  • Before discharge, ensure the child has been stable on discharge medications for at least 24 hours, with peak expiratory flow >75% of predicted and diurnal variability <25%, and confirm correct inhaler technique. 1
  • Provide a written asthma action plan, a peak flow meter, and arrange follow-up with the primary-care provider within 1 week and a respiratory specialist within 4 weeks. 1

Evidence Quality Note

  • These recommendations are based on high-quality evidence from the National Asthma Education and Prevention Program Expert Panel Report 3, FDA labeling for prednisolone, and British Thoracic Society guidelines. 1, 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.